Aayush GuptaOutpatient clinicSeven days a week
Weekdays 9 a.m. to 5 p.m., with an evening clinic from 6 to 8 p.m. Saturdays 9 to 5, and Sundays and holidays 9 to 1.
Dermatologist · Scientist · InventorAayush
Aayush
Gupta
Professor and Head, Department of Dermatology, Venereology and Leprology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune
He heads dermatology at Dr. D.Y. Patil, engineers scaffolds for skin repair in his Bioprinting Laboratory, and founded Qtanea Solutions, which makes the Vybe pain device and the OpenScholar research platform.
Founder and CEOQtanea Solutions
HeadBioprinting Laboratory
- 102 papers
Including JAAD, the British Journal of Dermatology, JAMA Dermatology and The Lancet Public Health.
- 7 trials
Principal investigator on industry studies from Phase 0 to Phase 4, including a Phase 3 leprosy trial.
- ₹7.5 crore
In research grants from ANRF, DBT, ICMR and others, and a seed fund for Qtanea Solutions.
- 5 patents
Granted in India and the United States, and a device company built on one of them.
01The department
Open seven days a week, with an evening clinic
Fifteen faculty and forty-five residents staff the dermatology department at Dr. D.Y. Patil Hospital in Pimpri, and they perform about 820 procedures a month.
Procedures a month820
About 390 a month in 2022 and about 820 a month in 2026, more than double. Each dot is ten procedures.
Teaching15 faculty · 45 residents
Fifteen residents join each year for the three-year MD, up from eleven. Eight hold ICMR thesis grants this year, up from three.
Inside the department
Clinics and procedures
Lasers and light
Hair reduction, tattoo and pigment removal, CO2 and erbium resurfacing, and photobiomodulation.
Dermatosurgery
Vitiligo surgery, hair transplantation, radiofrequency surgery and skin biopsies with the department's patented punch.
Injectables
Botulinum toxin, dermal fillers and intralesional steroid injections.
Peels and skin care
Chemical peels and medifacials for acne, pigmentation and ageing skin.
Imaging and measurement
Body mapping, dermoscopy, hair counts, skin colour, ultrasound and sebum measured with calibrated instruments.
Medical dermatology
Psoriasis, vitiligo, eczema, acne, hair loss, leprosy, sexually transmitted infections and rare genetic skin disease, with phototherapy and excimer light on site.
02Equipment
Six wavelengths, from ultraviolet to far infrared
Melanin, haemoglobin, tattoo ink and water each absorb a different band of light, so the wavelength decides which target a laser heats and how deep it works.
Schematic. Infrared beams are drawn in false colour.
308nmExcimer
Excimer light
- Absorbed by
- DNA and proteins in the epidermis
- Works at
- Epidermis and the top of the dermis
- Used for
- Vitiligo and psoriasis patches
Narrowband ultraviolet B calms the T cells that drive both diseases and stimulates melanocytes, so that vitiligo patches repigment.
More equipment
CO2 laser10,600 nm, for resurfacing, scars and removal of skin growths
Excimer308 nm targeted light for vitiligo and psoriasis
Phototherapy unitUltraviolet treatment for vitiligo, psoriasis and eczema
Radiofrequency cauterySeveral units, including an Ellman, for excisions and electrosurgery
Medifacial machineMedical facials for acne and pigmentation
Hair and skin imaging
Hair counted by software, skin measured by ultrasound
TrichoScan counts and measures every hair in a patch of scalp, and the DermaLab ultrasound probe reads skin thickness and density through the surface.
FotoFinder Aesthetics StudioThe software traces each hair, measures its thickness in micrometres and reports hair density, the share of terminal and vellus hairs, and follicular units.
Cortex DermaLabHigh-frequency ultrasound shows the layers of skin in cross-section, and further probes measure skin colour and sebum.
03Research
From the surface to the subcutis
Seven research programmes run from the top of the skin to the bottom, from cameras that read the surface to scaffolds that rebuild the dermis.
Section through human skin · schematicTap a numberClick a number or a programme below to zoom in
Select a research programme to zoom into the skin and read what the studies found
Basal layer and melanocytes
Vitiligo and pigment biology
Vitiligo skin carries a lower ultraviolet signature than non-melanoma skin cancers, and its epidermis shows a strong anti-skin cancer signature in miRNA networks. The long noncoding RNA MALAT1 and the microRNA miR-31-5p both protect melanin-deficient vitiligo keratinocytes against ultraviolet damage to DNA. An ANRF grant now funds an immune-competent 3D human skin model of vitiligo.
- 2026Nevus of Ota. Journal of the American Academy of Dermatology
- 2026microRNA miR-31-5p confers protection to melanin-deficient vitiligo keratinocytes against UV-B induced DNA damage by activating autophagy machinery. Scientific Reports
- 2025Minimal erythema dose variability in Indian skin: clinical implications across pigmentary and inflammatory dermatoses. Clinical and Experimental Dermatology
- 2024Stem cell factor-mediated upregulation of SIRT1 protects melanin-deprived keratinocytes against UV-induced DNA damage in individuals with vitiligo. The FASEB Journal
Research programmes
- Imaging and diagnostics (Above the skin surface): A point-of-care multispectral imaging device with artificial intelligence was tested against standard care for leg ulcers in leprosy in a within-person randomised pilot trial. A real-time fluorescence imaging device guided antibiotic treatment in superficial skin infections, and a handheld screening device detects skin and soft tissue infections. He holds a United States patent and two Indian patents, assigned to Adiuvo Diagnostics, on devices and systems that detect pathogens and other cells.
- Ichthyosis and genodermatoses (Stratum corneum): Severe autosomal recessive congenital ichthyosis carries a heavy psychosocial burden for patients and families, and secukinumab reduced its inflammation but improved scaling only mildly. His group contributed to IndiGenomes, a resource of genetic variants from over 1,000 Indian genomes, and uses whole exome sequencing to diagnose rare genodermatoses. An ICMR grant funded a topical transglutaminase-1 nanocomplex for enzyme replacement, and a DBT grant starting in December 2026 will test non-viral delivery in a TGM1-deficient 3D human skin model.
- Vitiligo and pigment biology (Basal layer and melanocytes): Vitiligo skin carries a lower ultraviolet signature than non-melanoma skin cancers, and its epidermis shows a strong anti-skin cancer signature in miRNA networks. The long noncoding RNA MALAT1 and the microRNA miR-31-5p both protect melanin-deficient vitiligo keratinocytes against ultraviolet damage to DNA. An ANRF grant now funds an immune-competent 3D human skin model of vitiligo.
- Procedures and pain (Epidermis and dermis): In a split-lesion study, vibration-assisted anaesthesia reduced pain during dermatologic procedures, and Qtanea Solutions now makes the vibration device, Vybe. Fractional CO2 laser delivery of topical corticosteroids hastened resolution of plaque sarcoidosis, and a laser technique has been applied to the upper airway to treat habitual snoring. Other papers compare platelet-rich plasma with microneedling for androgenetic alopecia.
- Leprosy and infection (Dermal nerves): He is the principal investigator at Dr. D.Y. Patil on LIGHT, a Phase 3 Johnson & Johnson trial of bedaquiline in multibacillary leprosy, and on a Phase 0 study of plasma PGL-I for treatment monitoring. His clinical papers cover leprosy, the differential diagnosis of leonine facies, scrofuloderma and nodular secondary syphilis with granulomatous inflammation.
- Wound healing and tissue engineering (Dermis): The Bioprinting Laboratory develops injectable granular hydrogels that combine extracellular-matrix mimicry with microporosity for skin tissue engineering. A DBT grant funds an automated spray device for autologous cell-grafted bioscaffolds. In vitiligo skin, miR-21-5p delays wound healing by regulating PDCD4 and Maspin.
- Quality of life (The whole patient): In leprosy, internalised stigma rather than disability drives the loss of quality of life. His group has related quality of life to clinical severity in vitiligo, acne, melasma and keloids, and measured the psychosocial impact of severe congenital ichthyosis.
04Clinical trials
Seven industry studies, from Phase 0 to Phase 4
Dr Gupta is the principal investigator on all seven, for sponsors that include Johnson & Johnson, Pfizer, Sun Pharma and Ahammune Biosciences.
7industry studies
5sponsors
0→4every trial phase from first-in-human evidence to post-marketing
5conditions: leprosy, vitiligo, alopecia areata, psoriasis and atopic dermatitis
Johnson & Johnson3 studiesPhase 0 · Phase 3 · Phase 4Leprosy and psoriasis
Pfizer1 studyRegistry, completedAtopic dermatitis, alopecia areata, vitiligo
Sun Pharma1 studyPlacebo-controlledAlopecia areata in adolescents
Ahammune Biosciences1 studyPhase 2Vitiligo
Systopic Laboratories1 studyObservationalHair health
Awaiting approval1
Placebo-controlledSun Pharma
Severe alopecia areata in adolescents
Deuruxolitinib
Submitted to DCGI
Full protocol title
A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients with Severe Alopecia Areata with an Open-Label Extension Period
Opening this autumn4
Phase 0Johnson & Johnson
Multibacillary leprosy, treatment monitoring
Skin assessment chart and plasma PGL-I
Opens October 2026
Full protocol title
A Phase 0, Clinical Study to Provide Fit-For-Purpose Evidence for the Standardized Skin Assessment Chart and to Evaluate Changes in Plasma Phenolic Glycolipid-I Over Time for Treatment Monitoring in Multibacillary Leprosy Patients
Phase 2Ahammune Biosciences
Non-segmental vitiligo
Topical AB1001
Opens October 2026
Full protocol title
A Phase II, multicenter, randomized study to evaluate safety and efficacy of topical AB1001 in adult patients with non-segmental vitiligo
ObservationalSystopic Laboratories
Hair health in adults
H-Vit hair serum
Opens October 2026
Full protocol title
An Open Label, Prospective, Single Arm Observation Study on H-Vit Hair Serum of Systopic Laboratories Pvt. Ltd. in Adults Looking to Improve Hair Health in Real World Clinical Practice
Phase 4Johnson & Johnson
Psoriasis
Guselkumab, subcutaneous
Opens November 2026
Full protocol title
A Phase IV, Multicenter, Non-comparative, Open-Label Study Evaluating the Safety and Efficacy of Guselkumab Administered Subcutaneously in the Treatment of Indian Patients with Psoriasis (CNTO1959PSO4039)
Under way1
Phase 3Johnson & Johnson
Multibacillary leprosy
Bedaquiline with rifampicin and clofazimine (LIGHT)
Under way since January 2025
Full protocol title
A Phase 3, Multicenter, Open-label, Rater-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Bedaquiline for the Treatment of Multibacillary Leprosy When Combined With Rifampicin and Clofazimine [LIGHT]
Completed1
RegistryPfizer
Atopic dermatitis, alopecia areata and vitiligo
Immuno-dermatology disease registry
Started March 2025, completed
Full protocol title
An Immuno-Dermatological Disease Registry to Understand the Burden of Atopic Dermatitis (AD), Alopecia Areata (AA), and Vitiligo in Indian Patients
05Research grants
Nearly ₹7.5 crore for research, from ichthyosis to CAR-T therapy
Dr Gupta has led nine extramural research projects funded by ANRF, DBT, ICMR, CSIR-IGIB, IADVL and industry, and Qtanea Solutions holds a ₹50 lakh seed fund.
₹7.5crore in total₹699 lakh across nine research projects and a ₹50 lakh seed fund
₹3crore, the largest single grantANRF, CAR-T therapy for lupus with IIT Kanpur
6fundersNational agencies, a national laboratory, a professional society and industry
6projects activeIncluding one sanctioned to start in December 2026
ANRFDBTICMRSeed fundIADVLCSIR-IGIBAdiuvo Diagnostics
ANRF₹3.77 croreAnusandhan National Research Foundation2 projects
DBT₹1.56 croreDepartment of Biotechnology2 projects
ICMR₹1.53 croreIndian Council of Medical Research2 projects
Seed fund₹50 lakhQtanea Solutions, the company that makes Vybe and OpenScholar1 project
IADVL₹5 lakhIndian Association of Dermatologists, Venereologists and Leprologists1 project
CSIR-IGIB₹4.5 lakhCSIR Institute of Genomics and Integrative Biology1 project
Adiuvo Diagnostics₹3.5 lakhAdiuvo Diagnostics1 project
2015201720192021202320252027Today
CSIR-IGIBSkin cell homeostasis
₹4.5 lakh
Adiuvo DiagnosticsPortable fluorescence dermascope to identify the pathogens of skin infection
₹3.5 lakh
ICMRTopical transglutaminase-1 nanocomplex for enzyme replacement in autosomal recessive congenital ichthyosis
₹67.8 lakh
IADVLMelanocyte and fibroblast cross-talk in keloids
₹5 lakh
DBTFully automated device that sprays a sterile bioscaffold carrying the patient’s own cells
₹85.5 lakh
ANRFSwitchable bispecific BCMA/CD19 CAR-T cell therapy for refractory systemic lupus erythematosus
₹3 crore
ANRFImmune-competent 3D human skin model of vitiligo
₹77 lakh
ICMRSkin-on-Chip for screening cosmetic endocrine disruptors relevant to PCOS
₹85 lakh
DBTNon-viral TGM1 delivery validated in a TGM1-deficient 3D human skin model
₹70.82 lakh
06Inventions
Built from problems seen in clinic
Qtanea Solutions makes Vybe for injection pain and OpenScholar for university research reporting, and the Department of Biotechnology funds the scaffold work in the Bioprinting Laboratory.
Qtanea Solutions
Vybe
Vybe vibrates the skin during an injection so that the patient feels less pain. In a split-lesion study published in Dermatologic Surgery, vibration-assisted anaesthesia reduced pain during dermatologic procedures.
Read the studyPubMedORCIDScopus
AG
Dr Aayush GuptaDermatology · Dr. D.Y. Patil Vidyapeeth
102Papers
748Citations
12h-index
✓NIRF and QS figures ready
Qtanea Solutions
OpenScholar
OpenScholar, also known as RIMS, is the research information platform Qtanea Solutions makes for universities. It imports every paper from PubMed and ORCID, tracks h-index and citations, and prepares the publication figures used for NIRF and QS rankings. Dr. D.Y. Patil Vidyapeeth runs its research reporting on it.
openscholar.in
Bioprinting Laboratory
Scaffolds for skin repair
The laboratory develops injectable granular hydrogels for skin tissue engineering. A DBT grant funds an automated device that sprays a bioscaffold carrying the patient's own cells.
Read the hydrogel paperPatentsFive granted
US 11,523,738Pathogen detection deviceUnited States
IN 323440Fluorescence detection of pathogensIndia
IN 564943Detection of cellular entitiesIndia
IN 559407Punch biopsy instrumentIndia
IN 499691Pain-abating deviceIndia
07Publications
102 papers
Dr Gupta is first or senior author on 64 of them, and his papers appear in The Lancet Public Health, JAMA Dermatology, the British Journal of Dermatology and the Journal of the American Academy of Dermatology.
102papers64 as first or senior author
748citationsCrossref, September 2026
12h-index12 papers cited at least 12 times
36papers in Q1 journalsThe top quarter of their field
12papers in journals with impact factor above 10Up to 26.5, The Lancet Public Health
Papers each year, with the running total. Select a year to filter the list.
53journals, including
The Lancet Public HealthIF 26.5The Lancet HIVIF 14.6Nucleic Acids ResearchIF 13.1Journal of the American Academy of DermatologyIF 12.3Journal of InfectionIF 11.9CMAJIF 11.3JAMA DermatologyIF 11.0British Journal of DermatologyIF 9.6
JEADVIF 8.0Biomaterials ScienceIF 6.1Journal of Investigative DermatologyIF 5.7Scientific ReportsIF 4.9Contact DermatitisIF 4.6Human GenomicsIF 4.3The FASEB JournalIF 4.2Experimental DermatologyIF 3.6
Most cited
134 citationsIndiGenomes: a comprehensive resource of genetic variants from over 1,000 Indian genomesNucleic Acids Research, 202072 citationsGenomics of rare genetic diseases: experiences from IndiaHuman Genomics, 201968 citationsQuality of life in acne vulgaris: relationship to clinical severity and demographic dataIndian Journal of Dermatology, Venereology and Leprology, 2016
2026When biologics fail: Tofacitinib-induced remission in a child with severe, genetically ambiguous psoriasisIndian Journal of Dermatology, Venereology and Leprology2026Port-wine capillary malformationJournal of the American Academy of Dermatology2026Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990–2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023The Lancet Public Health2026Comment on Case Series of Kaposi’s Varicelliform Eruption Associated with Underlying Primary DermatosesIndian Journal of Dermatology2026Nevus of OtaJournal of the American Academy of Dermatology2026Global, regional, and national burden of HIV/AIDS, 1990–2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023The Lancet HIV2026Decoding biological drug names in dermatology: The post-2022 WHO nomenclature revision and its implications for clinical practiceJournal of the American Academy of Dermatology2026Co-Occurrence of En Coup de Sabre, Parry-Romberg Syndrome, and Hemimasticatory Spasm: A Case ReportCase Reports in Dermatology2026microRNA miR-31-5p confers protection to melanin-deficient vitiligo keratinocytes against UV-B induced DNA damage by activating autophagy machineryScientific Reports2026Revisiting Leonine Facies: Toward More Inclusive Differential DiagnosesIndian Dermatology Online Journal2026Internalized stigma, not disability, drives quality‐of‐life loss in leprosy: A structural analysisJournal of the European Academy of Dermatology and Venereology2026Multifocal Pyoderma Gangrenosum Complicated by Multiple Organ Dysfunction2026Ectopic acanthosis nigricans at a post-syndactyly surgical site: An unusual reactive epidermal phenomenonJournal of Cutaneous and Aesthetic Surgery2026Bioorthogonally reinforced injectable granular hydrogels synergizing ECM mimicry with microporosity for skin tissue engineeringBiomaterials Science2026Laser-Based Rejuvenation of the Upper Airway: A Novel Non-Surgical Approach to Habitual SnoringJournal of Lasers in Medical Sciences2025Familial Woolly HairAnnals of African Medicine2025Intertriginous Pityriasis Lichenoides Chronica: An Atypical PresentationAnnals of African Medicine2025Minimal erythema dose variability in Indian skin: clinical implications across pigmentary and inflammatory dermatosesClinical and Experimental Dermatology2025Disrupted cholesterol biosynthesis and hair follicle stem cell impairment in the onset of alopeciaPLoS ONE2025Vibration-Assisted Anesthesia Reduces Pain in Dermatologic Procedures: A Split-Lesion StudyDermatologic Surgery2025A Within-Person Randomized Controlled Pilot Study to Evaluate the Ability of a Point-of-Care Artificial Intelligence-Enabled Multispectral Imaging Device to Manage Leg Ulcers in LeprosyAdvances in Skin & Wound Care2025Levetiracetam-Aggravated Severe Treatment-Resistant AcneIndian Dermatology Online Journal2025A Curious Case of Acute Fever with Vesicular Rash in an InfantIndian Journal of Paediatric Dermatology2025Comparative study of platelet rich plasma therapy versus microneedling as a treatment modality for androgenetic alopeciaIP Indian Journal of Clinical and Experimental Dermatology2025Amoxicillin-clavulanic Acid and Trimethoprim/ Sulphamethoxazole Combination Therapy for Actinomycetoma in an Elderly Farmer: A Case ReportJournal of Clinical and Diagnostic Research2025T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblastsJournal of Investigative Dermatology2025Borderline Tuberculoid LeprosyJEADV Clinical Practice2025Scrofuloderma in a 27-year-old womanCanadian Medical Association Journal2025Decoding the Lichenoid Riddle of Red TattoosIndian Dermatology Online Journal2025Dermoscopy: Solving the diagnostic puzzle in vulvar vestibular papillomatosisIndian Journal of Sexually Transmitted Diseases and AIDS2025Body Focused Repetitive Behavior at an Unusual Site and in an Unusual Pattern - Symmetrical TrichotillomaniaInternational Journal of Trichology2025Unusual Co-occurrence of Primary Anetoderma and Isolated Facial Angiofibromas: A Report of Two CasesAnnals of African Medicine2024Stem cell factor-mediated upregulation of SIRT1 protects melanin-deprived keratinocytes against UV-induced DNA damage in individuals with vitiligoThe FASEB Journal2024Addressing Diagnostic and Therapeutic Challenges in a Case of Concurrent Tinea and Plaque PsoriasisCase Reports in Dermatology2024Meta‐analysis reveals a lower ‘UV signature’ in vitiligo skin compared to non‐melanoma skin cancersExperimental Dermatology2024A Rapid and Scalable Multiplex PCR-Based Next-Generation Amplicon Sequencing Method for Familial Hypercholesterolemia Genetic ScreeningThe Journal of Applied Laboratory Medicine2024Pyoderma Gangrenosum: A Presenting Feature of Rheumatoid ArthritisCureus2024Trends in Inpatient Dermatology and The Impact of the COVID-19 Pandemic at A Tertiary Care Facility in Western IndiaNational Journal of Community Medicine2024A Rapid Point-of-care Fluorescence Imaging Device Helps Prevent Graft Rejection Post Modified Radical MastectomyJournal of Global Infectious Diseases2024Cutaneous Granulomatous Reaction Secondary to MesotherapyDermatitis2024ChloracneJAMA Dermatology2024Homozygous familial hypercholesterolemia with xanthomas and a recurrent mutationIndian Journal of Dermatology, Venereology and Leprology2024Occurrence of Bullous Pemphigoid in a Longstanding Case of Rheumatoid Arthritis in an Indian Patient: A Rare AssociationCureus2024Dermoscopic Correlation of an Eccentric Case of Kindler SyndromeCureus2024LeprosyJournal of the American Academy of Dermatology2024Impact of COVID-19 outbreak on healthcare workers in a Tertiary Healthcare Center in India: a cross sectional studyScientific Reports2024VitiligoJournal of the American Academy of Dermatology2023Psychosocial impact of severe autosomal recessive congenital ichthyosisBritish Journal of Dermatology2023Fractional CO2 laser-induced delivery of topical corticosteroids hastens resolution of localized plaque sarcoidosisJournal of Cutaneous and Aesthetic Surgery2023Mucormycosis: An Addendum to India’s COVID-19 WoesMedical Journal of Dr. D.Y. Patil Vidyapeeth2023Acral Persistent Papular Mucinosis with Lichenoid Drug Reaction due to Isotretinoin on Background of Dyschromatosis Universalis HereditariaClinical Dermatology Review2023A case of incomplete Klippel-Trenaunay syndrome with schizophrenia and global cerebral atrophyIndustrial Psychiatry Journal2022Whole-Exome Sequencing of Vitiligo Lesions Indicates Lower Burden of Somatic Variations: Implications in Risk for Nonmelanoma Skin CancersJournal of Investigative Dermatology2022Genome-wide profiling reveals pervasive transcriptional alterations in fibroblasts derived from lesional skin in vitiligo including a reduced potential to proliferateExperimental Dermatology2022Secukinumab significantly reduces inflammation but only mildly improves scaling in four cases of autosomal recessive congenital ichthyosisClinical and Experimental Dermatology2022Quality-of-life of people with keloids and its correlation with clinical severity and demographic profilesWound Repair and Regeneration2022Deoxycholic Acid Injection in the Management of Difficult-to-Remove Subcutaneous LipomasDermatologic Surgery2022Trichotillomania2022Nodular secondary syphilis with granulomatous inflammationIndian Journal of Sexually Transmitted Diseases and AIDS2021Erythema multiforme after Covishield/ChAdOx1 vaccinationDermatologic Therapy2021Genetic epidemiology of autoinflammatory disease variants in Indian population from 1029 whole genomesJournal of Genetic Engineering and Biotechnology2021Differential regulation of miR-21-5p delays wound healing of melanocyte-deprived vitiligo skin by modulating the expression of tumor-suppressors PDCD4 and MaspinJournal of Cellular Physiology2021SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare workerJournal of Infection2021Plexiform Neurofibromatosis2021Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population GenomesPharmacogenomics2021Integrated analysis of miRNA‐mRNA networks reveals a strong anti‐skin cancer signature in vitiligo epidermisExperimental Dermatology2021Utility of a real-time fluorescence imaging device in guiding antibiotic treatment in superficial skin infectionsIndian Journal of Dermatology, Venereology and Leprology2020The long noncoding RNA MALAT1 suppresses miR‐211 to confer protection from ultraviolet‐mediated DNA damage in vitiligo epidermis by upregulating sirtuin 1British Journal of Dermatology2020IndiGenomes: a comprehensive resource of genetic variants from over 1000 Indian genomesNucleic Acids Research2020Rapid handheld screening device to detect skin and soft tissue infectionsProceedings of SPIE2020Lesional skin in vitiligo exhibits delayed in vivo reepithelialization compared to the nonlesional skinWound Repair and Regeneration2019Intralesional rituximab salvages refractory scalp lesions in a case of pemphigus vulgarisDermatologic Therapy2019Genomics of rare genetic diseases: experiences from IndiaHuman Genomics2019Improvement in the quality of life of a patient of ectodermal dysplasia with reconstructive surgeriesJournal of Cutaneous and Aesthetic Surgery2018Clinical, dermoscopic and histopathological findings in a case of Favre Racouchot syndrome2018A case of primary essential Cutis verticis gyrata2018Hand eczema in nurses, nursing auxiliaries and cleaners: A cross‐sectional study from a tertiary hospital in western IndiaContact Dermatitis2018Correlating impairment of quality of life and severity of melasma: A cross-sectional study of 141 patientsIndian Journal of Dermatology2018Giant molluscum contagiosum unmasked probably during an immune reconstitution inflammatory syndromeIndian Journal of Sexually Transmitted Diseases and AIDS2018Acquired angiokeratomas of the vulvaIndian Journal of Sexually Transmitted Diseases and AIDS2017Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligoScientific Reports2017Four cases of recalcitrant pemphigus vulgaris salvaged with rituximabMedical Journal of Dr. D.Y. Patil University2017Association of dermatoses with duration and quantum of alcohol intake: A comparative cross-sectional studyIndian Journal of Dermatology2017Quality of life in vitiligo: Relationship to clinical severity and demographic dataPigment International2016Prevalence of metabolic syndrome as per the NCEP and IDF definitions vis-a-vis severity and duration of psoriasis in a semi-urban Maharashtrian population: A case control studyDiabetes & Metabolic Syndrome2016Lingering immune dysregulation of inflammatory dermatoses, particularly psoriasis, probably drives metabolic syndrome culminating in cardiovascular damage and needs preventive public health guidelines as well as comprehensive managementMedical Journal of Dr. D.Y. Patil University2016Some other serendipitous discoveries in dermatologyIndian Journal of Dermatology2016Measuring severity of acne vulgaris and impairment in quality of life of its patients and aiming for their concomitant reduction facilitates comprehensive managementJournal of Health Research and Reviews2016Occupational contact dermatitis caused by dimethylformamideIndian Dermatology Online Journal2016Quality of life in acne vulgaris: Relationship to clinical severity and demographic dataIndian Journal of Dermatology, Venereology and Leprology2016Severe recalcitrant psoriasis treated with itolizumab, a novel anti-CD6 monoclonal antibodyIndian Journal of Dermatology, Venereology and Leprology2015The use of chalazion clamps to create adequate sustained pressure for slit skin smearJournal of the American Academy of Dermatology2015Three cases of suspected chloracne in a family from PuneIndian Journal of Dermatology, Venereology and Leprology2015Case Report: Whole exome sequencing helps in accurate molecular diagnosis in siblings with a rare co-occurrence of paternally inherited 22q12 duplication and autosomal recessive non-syndromic ichthyosisF1000Research2015Whole‐exome sequencing solves diagnostic dilemma in a rare case of sporadic acrokeratosis verruciformisJournal of the European Academy of Dermatology and Venereology2015Pemphigus foliaceus occurring with adenocarcinoma of prostateIndian Journal of Dermatology, Venereology and Leprology2015Cultural adaptation of the Cardiff Acne Disability Index to a hindi speaking population: A pilot studyIndian Journal of Dermatology2015"Giant" tuberous xanthomas in a 9-year-old child with homozygous familial hypercholesterolemiaIndian Journal of Paediatric Dermatology2014Ultrastructural Investigations in an Autosomal Recessively Inherited Case of Dyschromatosis Universalis HereditariaActa Dermato-Venereologica2014Becker nevus syndrome; probably the first report of concurrent acrally located congenital BN, soft tissue hypertrophy and fused carpal bonesJournal of the European Academy of Dermatology and Venereology2014Human demodex mite: The versatile mite of dermatological importanceIndian Journal of Dermatology2014An unusual pattern of alopecia areataInternational Journal of Trichology
08Record
Appointments and awards
At Dr. D.Y. Patil
- 01Professor and HeadDepartment of Dermatology, Venereology and Leprology
- 02Director of Strategic InitiativesDr. D.Y. Patil Medical College, Hospital and Research Centre
- 03Head, Bioprinting LaboratoryDr. D.Y. Patil Vidyapeeth
- 04Programme DirectorMD Dermatology residency
Industry and editorial
- 05Founder and CEOQtanea Solutions Private Limited
- 06Clinical Advisory BoardAdiuvo Diagnostics
- 07Scientific AdvisorClarivo Biosciences
- 08Consulting EditorClinical, Cosmetic and Investigational Dermatology
Awards
Two awards from the National Academy of Medical Sciences, the Lokmat Dhanvantri Award, two journal awards and a science fellowship in Japan.
National Academy of Medical SciencesDr A.S. Thambaiah AwardNAMSCON 2022, Jaipur
National Academy of Medical SciencesAmritsar Award2022–23
LokmatDhanvantri Award2023
Indian Journal of Dermatology, Venereology and LeprologyTwo category awardsJournal awards
Japan Science and Technology AgencySakura Science FellowFellowship in Japan
Member ofIADVLlife memberInternational Society of DermatologyGUaRDIANrare-disease genomics consortium
09On stage
From Jaipur to Seoul
Dr Gupta has lectured at the National Academy of Medical Sciences in Jaipur, been honoured at ROOTS in Pune and attended the QS Higher Ed Summit at Korea University in Seoul.
10Explainers
Two-minute films on skin
Short animated films that explain common skin problems and their treatment, in English and Hindi, each checked and approved by Dr Gupta.
Latest film · Hindi · 2 min
क्या आपको आधा SPF भी मिल रहा है?
Zyadatar log utni sunscreen ki aadhi lagate hain jitni SPF test mein use hoti hai, ya usse bhi kam. Yeh film dikhati hai ki itni patli layer tube par likhe protection ko kitna ghatati hai. SPF test mein skin ke har square centimetre par 2 mg cream lagayi jati hai. Aadhi cream lagane par SPF zyada se zyada lagbhag aadha rehta hai, aur kai studies mein isse kaafi kam mila. Ooncha SPF is kami ka kuch hissa bharta hai, par sirf wahin jahan cream lagi ho. Film ke aakhir mein chehre aur gardan ke liye kitni cream lagani hai, aur apni tube jaanchne ka ek aasaan tareeka hai.
26 October 2026 · 5 chapters · 11 sources
English · 3 minWhat SPF 30 Really Means24 October 2026
Hindi · 4 minSPF 30 का असल मतलब क्या है?19 October 2026
English and Hindi · 2 minIs Your ‘Magic Cream’ Secretly a Steroid?14 October 2026
All explainer films Subscribe on YouTube
General health education, not medical advice for any individual. Narration uses an AI voice; the script and animation are prepared with AI assistance, then checked and approved by Dr Gupta.
11Advisory
Work with Dr Gupta
Dr Gupta takes on expert calls, advisory board seats and reviews of trial protocols and devices for companies, investors and universities. Write to aayushggupta@gmail.com or use the form.
- Dermatology drugs: biologics, oral targeted therapies and non-steroidal topicals
- Design and conduct of clinical trials at Indian sites
- Dermatology devices, diagnostics and imaging with artificial intelligence
- Rare genodermatoses and genomics
- Research information systems for universities
12Questions
Quick answers
The questions people ask most often, each answered in a few lines.
Aayush Gupta is Professor and Head of the Department of Dermatology, Venereology and Leprology at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pimpri, Pune. He is Director of Strategic Initiatives at the medical college, heads the Bioprinting Laboratory of Dr. D.Y. Patil Vidyapeeth and directs the MD dermatology residency programme. He founded Qtanea Solutions Private Limited, which makes Vybe, a vibratory anaesthesia device, and OpenScholar, a research information platform for universities, and he holds five patents in India and the United States. He has published 102 papers, is principal investigator on seven industry clinical trials and has raised nearly ₹7.5 crore for research, made up of nine extramural research grants and a ₹50 lakh seed fund for his company Qtanea Solutions. His research covers vitiligo, ichthyosis and other genodermatoses, leprosy, wound healing and imaging with artificial intelligence.
Vybe is a vibratory anaesthesia device made by Qtanea Solutions, the company Dr Gupta founded. It vibrates the skin during an injection so that the patient feels less pain. In a split-lesion study published in Dermatologic Surgery, vibration-assisted anaesthesia reduced pain during dermatologic procedures.
OpenScholar, also known as RIMS, is a research information platform made by Qtanea Solutions, the company Dr Gupta founded. It imports a university's papers from PubMed and ORCID, tracks h-index and citations, builds a profile page for each researcher and prepares the publication figures used for NIRF and QS rankings. Dr. D.Y. Patil Vidyapeeth runs its research reporting on OpenScholar.
Dr Gupta holds five granted patents. Three of them, US 11,523,738 and Indian patents 323440 and 564943, are assigned to Adiuvo Diagnostics and protect devices that detect pathogens and other cells. Indian patent 559407 protects a punch biopsy instrument, and Indian patent 499691 protects the pain-abating device on which Vybe is built.
Dr Gupta is the principal investigator on seven industry studies at Dr. D.Y. Patil. LIGHT, a Phase 3 Johnson & Johnson trial of bedaquiline in multibacillary leprosy, has been under way since January 2025, and a Pfizer registry of atopic dermatitis, alopecia areata and vitiligo is complete. Four studies open in October and November 2026: a Phase 0 Johnson & Johnson study of plasma PGL-I in leprosy, a Phase 2 study of topical AB1001 in vitiligo for Ahammune Biosciences, an observational study of H-Vit hair serum for Systopic Laboratories and a Phase 4 study of guselkumab in psoriasis for Johnson & Johnson. A Sun Pharma trial of deuruxolitinib in adolescents with severe alopecia areata awaits DCGI approval.
Dr Gupta has raised nearly ₹7.5 crore for research, made up of nine extramural research projects and a ₹50 lakh seed fund for Qtanea Solutions. The largest is a ₹3 crore Anusandhan National Research Foundation grant, with IIT Kanpur, to develop switchable bispecific BCMA/CD19 CAR-T cell therapy for refractory systemic lupus erythematosus. DBT funds an automated device that sprays a bioscaffold carrying the patient's own cells, and a second DBT grant from December 2026 will test non-viral transglutaminase-1 delivery for congenital ichthyosis. ICMR funds a Skin-on-Chip platform for cosmetic endocrine disruptors, and ANRF funds an immune-competent 3D skin model of vitiligo. Earlier grants came from ICMR, CSIR-IGIB, IADVL and Adiuvo Diagnostics.
The outpatient clinic of the Department of Dermatology, Venereology and Leprology at Dr. D.Y. Patil Medical College, Hospital and Research Centre in Pimpri, Pune, is open from 9 a.m. to 5 p.m. and again from 6 to 8 p.m. on weekdays, from 9 a.m. to 5 p.m. on Saturdays, and from 9 a.m. to 1 p.m. on Sundays and holidays. The department has fifteen faculty and forty-five residents and performs about 820 procedures a month.
Yes. He advises companies, investors and universities on dermatology drugs, clinical trials at Indian sites, dermatology devices and diagnostics, rare genodermatoses and research information systems. Enquiries can be sent through the form on this page.